This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oteo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oteo, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2004, p. 5571-5577, Vol. 42, No. 12
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.12.5571-5577.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Trends in Antimicrobial Resistance in 1,968 Invasive Streptococcus pneumoniae Strains Isolated in Spanish Hospitals (2001 to 2003): Decreasing Penicillin Resistance in Children's Isolates

Jesús Oteo,1 Edurne Lázaro,2 Francisco J. de Abajo,2 Fernando Baquero,3 José Campos,1* and Spanish Members of the European Antimicrobial Resistance Surveillance System{dagger}

Centro Nacional de Microbiología,1 Agencia Española del Medicamento, Ministry of Health, Majadahonda,2 Department of Microbiology, Hospital Ramón y Cajal, Madrid, Spain3

Received 21 June 2004/ Returned for modification 26 July 2004/ Accepted 29 July 2004

To address the public health problem of antibiotic resistance, the European Union (EU) founded the European Antimicrobial Resistance Surveillance System. A network of 40 hospitals that serve approximately 30% of the Spanish population (about 12 million) participated. Each laboratory reported data on antimicrobial susceptibility testing using standard laboratory procedures that were evaluated by an external quality control program. The antibiotic consumption data were obtained from the National Health System. We compared the antibiotic susceptibility of Spanish isolates of invasive Streptococcus pneumoniae (2001 to 2003) with antibiotic consumption. Invasive S. pneumoniae was isolated from 1,968 patients, 20% of whom were children at or below the age of 14 years. Of non-penicillin-susceptible strains (35.6%; 95% confidence interval, 34 to 37.2), 26.4% were considered intermediate and 9.2% were considered resistant. Between 2001 and 2003, penicillin resistance decreased from 39.5 to 33% overall and from 60.4 to 41.2% in children at or below the age of 14 years (P = 0.002). Resistance to erythromycin was at 26.6%, and coresistance with penicillin was at 19.1%. Of total isolates, the ciprofloxacin MIC was >2 µg/ml for 2.1%, with numbers increasing from 0.4% (2001) to 3.9% (2003). Total antibiotic use decreased from 21.66 to 19.71 defined daily doses/1,000 inhabitants/day between 1998 and 2002. While consumption of broad-spectrum penicillins, cephalosporins, and erythromycin declined, use of amoxicillin-clavulanate and quinolones increased by 17.5 and 27%, respectively. The frequency of antibiotic resistance in invasive S. pneumoniae in Spain was among the highest in the EU. However, a significant decrease in penicillin resistance was observed in children. This decrease coincided with the introduction of a heptavalent conjugate pneumoccocal vaccine (June 2001) and with a global reduction in antibiotic consumption levels.


* Corresponding author. Mailing address: Centro Nacional de Microbiología, Instituto de Salud Carlos III, Carretera Pozuelo a Majadahonda, 28220, Majadahonda, Madrid, Spain. Phone: 34 91 822 3650. Fax: 34 91 509 7966. E-mail: jcampos{at}isciii.es.

{dagger} Spanish members of EARSS are listed in Acknowledgments.


Journal of Clinical Microbiology, December 2004, p. 5571-5577, Vol. 42, No. 12
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.12.5571-5577.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Su, L.-H., Wu, T.-L., Kuo, A.-J., Chia, J.-H., Chiu, C.-H. (2009). Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18. J Antimicrob Chemother 64: 336-342 [Abstract] [Full Text]  
  • Van Eldere, J., Mera, R. M., Miller, L. A., Poupard, J. A., Amrine-Madsen, H. (2007). Risk Factors for Development of Multiple-Class Resistance to Streptococcus pneumoniae Strains in Belgium over a 10-Year Period: Antimicrobial Consumption, Population Density, and Geographic Location. Antimicrob. Agents Chemother. 51: 3491-3497 [Abstract] [Full Text]  
  • Campos, J., Ferech, M., Lazaro, E., de Abajo, F., Oteo, J., Stephens, P., Goossens, H. (2007). Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 60: 698-701 [Abstract] [Full Text]  
  • Obando, I., Arroyo, L., Sanchez-Tatay, D., Valles, X., Torres, A. (2007). Decrease in Drug Resistance in Pneumococcal Community-Acquired Pneumonia. Chest 132: 359-360 [Full Text]  
  • Sadowy, E., Izdebski, R., Skoczynska, A., Grzesiowski, P., Gniadkowski, M., Hryniewicz, W. (2007). Phenotypic and Molecular Analysis of Penicillin-Nonsusceptible Streptococcus pneumoniae Isolates in Poland. Antimicrob. Agents Chemother. 51: 40-47 [Abstract] [Full Text]  
  • Dias, R., Louro, D., the Antimicrobial Resistance Surveillance Program, , Canica, M. (2006). Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Isolates in Portugal over an 11-Year Period.. Antimicrob. Agents Chemother. 50: 2098-2105 [Abstract] [Full Text]  
  • Brandileone, M.-C. C., Casagrande, S. T., Guerra, M.-L. L. S., Zanella, R. C., Andrade, A.-L. S. S., Fabio, J.-L. D. (2006). Increase in numbers of {beta}-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage.. J Med Microbiol 55: 567-574 [Abstract] [Full Text]  
  • Siquier, B., Sanchez-Alvarez, J., Garcia-Mendez, E., Sabria, M., Santos, J., Pallares, R., Twynholm, M., Dal-Re, R., on behalf of the 620 Clinical Study Group, (2006). Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 57: 536-545 [Abstract] [Full Text]  
  • Cafini, F., del Campo, R., Alou, L., Sevillano, D., Morosini, M. I., Baquero, F., Prieto, J., on behalf of the Spanish Pneumococcal Network (G03, (2006). Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain. J Antimicrob Chemother 57: 224-229 [Abstract] [Full Text]